Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ameren (AEE) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Ameren (AEE) over the last 17 years, with Q3 2025 value amounting to $8.0 million.

  • Ameren's Gains from Investment Securities rose 11126.76% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.0 million, marking a year-over-year increase of 5390.62%. This contributed to the annual value of -$92.0 million for FY2024, which is 28333.33% down from last year.
  • According to the latest figures from Q3 2025, Ameren's Gains from Investment Securities is $8.0 million, which was up 11126.76% from -$72.0 million recorded in Q2 2025.
  • Ameren's 5-year Gains from Investment Securities high stood at $435.0 million for Q4 2021, and its period low was -$72.0 million during Q2 2025.
  • Its 5-year average for Gains from Investment Securities is $14.5 million, with a median of -$5.0 million in 2022.
  • The largest annual percentage gain for Ameren's Gains from Investment Securities in the last 5 years was 18125.0% (2025), contrasted with its biggest fall of 250000.0% (2025).
  • Over the past 5 years, Ameren's Gains from Investment Securities (Quarter) stood at $435.0 million in 2021, then plummeted by 101.15% to -$5.0 million in 2022, then tumbled by 780.0% to -$44.0 million in 2023, then surged by 81.82% to -$8.0 million in 2024, then surged by 200.0% to $8.0 million in 2025.
  • Its Gains from Investment Securities stands at $8.0 million for Q3 2025, versus -$72.0 million for Q2 2025 and $13.0 million for Q1 2025.